Brought to you by 
Danaher buys ITC from Thoratec for $110mm; terminated
04 Nov 2022
Executive Summary
Thoratec Corp. has agreed to sell its International Technidyne Corp. division (point-of-care diagnostic devices) to Danaher Corp. (medical instrumentation) for $110mm in cash. Shareholders may also receive a $26mm earn-out (paid over a three-year-period) based on sales of ITC's alternate site business unit.
Deal Industry
- In Vitro Diagnostics
- Medical Devices
-
In Vitro Diagnostics
- Hematology, Coagulation
Deal Status
- Withdrawn
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Includes Earnout
- Payment Includes Cash for Equity
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Danaher buys ITC from Thoratec for $110mm; terminated
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice